Acthar Gel

MOQ3000000 Box
H.P. Acthar Gel injectable solution80 units/mL
5 milliliters,H.P. Acthar Gel injectable solution
Acthar Gelwhite
Supply TypeExporter, Supplier, Retailer, Distributor, Importer, Trader
Preferred Buyer Location India, Benin, Egypt, South Africa, Argentina, Brazil, Canada, Mexico, United States, Afghanistan, Bahrain, Bangladesh, China, Hong Kong, India, Indonesia, Iran (Islamic Republic of), Iraq, Israel, Japan, Jordan, Kuwait, Malaysia, Nepal, Oman, Pakistan, Philippines, Saudi Ara bia, Singapore, Korea, Republic of, Sri Lanka, Syrian Arab Republic, Taiwan, Thailand, Turkey, United Arab Emirates, Viet Nam, Yemen, France, Germany, Greece, Italy, Netherlands, Poland, Romania, Russian Federation, Spain, Ukraine, United Kingdom, Australia, New Zealand

The H.P. Acthar Gel injectable solution (80 units/mL) is around $40,613 for a supply of 5 milliliters, depending on the supplier. Medicare cannot bar access to medications like Acthar, even in the....

Company Information

5.0/5

Member Since 6 Years
Nature of Business Manufacturer
Year of Establishment 2017

Ask for more detail from the seller

Report incorrect details

Product Details
Company Details

The H.P. Acthar Gel injectable solution (80 units/mL) is around $40,613 for a supply of 5 milliliters, depending on the supplier.

Medicare cannot bar access to medications like Acthar, even in the face of rising expense and questions about efficacy, Aaron Albright, a spokesman for the Centers for Medicare and Medicaid Services, said in a written statement. The law mandates that Medicare's drug program, known as Part D, cover drugs for the uses authorized by the Food and Drug Administration, he said.

Since Acthar came on the market in 1952, the rules about F.D.A. approval have changed. At the time, drug companies simply had to demonstrate that a drug was safe, rather than that it was effective. Acthar was initially authorized as a treatment for more than 50 diseases and conditions.

Acthar isn't prescribed often, just 3,387 times in Medicare in 2012. But Part D spent an average of $41,763 per prescription, making it one of the most expensive drugs around.